Synthesis and evaluation of multi-target-directed ligands against Alzheimer's disease based on the fusion of donepezil and ebselen.

A novel series of compounds obtained by fusing the cholinesterase inhibitor donepezil and the antioxidant ebselen were designed as multi-target-directed ligands against Alzheimer's disease. An in vitro assay showed that some of these molecules did not exhibit highly potent cholinesterase inhibitory activity but did have various other ebselen-related pharmacological effects. Among the molecules, compound 7d, one of the most potent acetylcholinesterase inhibitors (IC50 values of 0.042 μM for Electrophorus electricus acetylcholinesterase and 0.097 μM for human acetylcholinesterase), was found to be a strong butyrylcholinesterase inhibitor (IC50 = 1.586 μM), to possess rapid H2O2 and peroxynitrite scavenging activity and glutathione peroxidase-like activity (ν0 = 123.5 μM min(-1)), and to be a substrate of mammalian TrxR. A toxicity test in mice showed no acute toxicity at doses of up to 2000 mg/kg. According to an in vitro blood-brain barrier model, 7d is able to penetrate the central nervous system.

[1]  A. Holmgren,et al.  Ebselen: A substrate for human thioredoxin reductase strongly stimulating its hydroperoxide reductase activity and a superfast thioredoxin oxidant , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Maurizio Recanatini,et al.  Multi-target-directed ligands to combat neurodegenerative diseases. , 2008, Journal of medicinal chemistry.

[3]  M. Decker,et al.  Homobivalent quinazolinimines as novel nanomolar inhibitors of cholinesterases with dirigible selectivity toward butyrylcholinesterase. , 2006, Journal of medicinal chemistry.

[4]  C. Berr,et al.  Increased selenium intake in elderly high fish consumers may account for health benefits previously ascribed to omega-3 fatty acids , 2009, The journal of nutrition, health & aging.

[5]  W. Pryor,et al.  DNA Damage and Oxidation of Thiols Peroxynitrite Causes in Rat Thymocytes , 1995 .

[6]  Manuela G. López,et al.  Multipotent drugs with cholinergic and neuroprotective properties for the treatment of Alzheimer and neuronal vascular diseases. I. Synthesis, biological assessment, and molecular modeling of simple and readily available 2-aminopyridine-, and 2-chloropyridine-3,5-dicarbonitriles. , 2010, Bioorganic & medicinal chemistry.

[7]  Y. Geletii,et al.  Peroxynitrite scavenging by different antioxidants. Part I: convenient assay. , 1999, Nitric oxide : biology and chemistry.

[8]  H. Feldman,et al.  Treatment of Alzheimer's disease; current status and new perspectives , 2003, The Lancet Neurology.

[9]  J. Sussman,et al.  Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs. , 1999, Structure.

[10]  A. Krol,et al.  The selenium to selenoprotein pathway in eukaryotes: more molecular partners than anticipated. , 2009, Biochimica et biophysica acta.

[11]  J. Dartigues,et al.  Selenium and Oxygen‐Metabolizing Enzymes in Elderly Community Residents: A Pilot Epidemiological Study , 1993, Journal of the American Geriatrics Society.

[12]  Wei Huang,et al.  Novel dual inhibitors of AChE and MAO derived from hydroxy aminoindan and phenethylamine as potential treatment for Alzheimer's disease. , 2002, Journal of medicinal chemistry.

[13]  D. Mahan.  Effect of organic and inorganic selenium sources and levels on sow colostrum and milk selenium content. , 2000, Journal of animal science.

[14]  Jerry J Buccafusco,et al.  Multi-functional drugs for various CNS targets in the treatment of neurodegenerative disorders. , 2005, Trends in pharmacological sciences.

[15]  C. Geula,et al.  Rivastigmine is a potent inhibitor of acetyl- and butyrylcholinesterase in Alzheimer's plaques and tangles , 2005, Brain Research.

[16]  M. Decker,et al.  Novel tricyclic quinazolinimines and related tetracyclic nitrogen bridgehead compounds as cholinesterase inhibitors with selectivity towards butyrylcholinesterase. , 2006, Bioorganic & medicinal chemistry.

[17]  I. Qureshi,et al.  Evaluation of Abelmoschus moschatus extracts for antioxidant, free radical scavenging, antimicrobial and antiproliferative activities using in vitro assays , 2011, BMC complementary and alternative medicine.

[18]  C. Pérez,et al.  Pyridonepezils, new dual AChE inhibitors as potential drugs for the treatment of Alzheimer's disease: synthesis, biological assessment, and molecular modeling. , 2012, European journal of medicinal chemistry.

[19]  Tao Wang,et al.  Ebselen inhibits iron-induced tau phosphorylation by attenuating DMT1 up-regulation and cellular iron uptake , 2012, Neurochemistry International.

[20]  A. Holmgren,et al.  A Novel Antioxidant Mechanism of Ebselen Involving Ebselen Diselenide, a Substrate of Mammalian Thioredoxin and Thioredoxin Reductase* , 2002, The Journal of Biological Chemistry.

[21]  Kum Kum Khanna,et al.  From selenium to selenoproteins: synthesis, identity, and their role in human health. , 2007, Antioxidants & redox signaling.

[22]  A. Spector,et al.  Development of Synthetic Compounds with Glutathione Peroxidase Activity. , 1989 .

[23]  B. Ames,et al.  An adduct between peroxynitrite and 2'-deoxyguanosine: 4,5-dihydro-5-hydroxy-4-(nitrosooxy)-2'-deoxyguanosine. , 1996, Chemical research in toxicology.

[24]  Vincenza Andrisano,et al.  Rational approach to discover multipotent anti-Alzheimer drugs. , 2005, Journal of medicinal chemistry.

[25]  H. Sugimoto,et al.  Donepezil hydrochloride (E2020) and other acetylcholinesterase inhibitors. , 2000, Current medicinal chemistry.

[26]  H. Steinbrenner,et al.  Protection against reactive oxygen species by selenoproteins. , 2009, Biochimica et biophysica acta.

[27]  C. Luchese,et al.  Sub-chronical exposure to diphenyl diselenide enhances acquisition and retention of spatial memory in rats , 2008, Brain Research.

[28]  K. Courtney,et al.  A new and rapid colorimetric determination of acetylcholinesterase activity. , 1961, Biochemical pharmacology.

[29]  Irene Bolea,et al.  Synthesis, biological evaluation, and molecular modeling of donepezil and N-[(5-(benzyloxy)-1-methyl-1H-indol-2-yl)methyl]-N-methylprop-2-yn-1-amine hybrids as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease. , 2011, Journal of medicinal chemistry.

[30]  J. Rocha,et al.  Diphenyl diselenide and analogs are substrates of cerebral rat thioredoxin reductase: A pathway for their neuroprotective effects , 2011, Neuroscience Letters.

[31]  N. Inestrosa,et al.  Acetylcholinesterase, a senile plaque component, affects the fibrillogenesis of amyloid-β-peptides , 1995, Neuroscience Letters.

[32]  J S Beckman,et al.  Peroxynitrite formation from macrophage-derived nitric oxide. , 1992, Archives of biochemistry and biophysics.

[33]  Claudia Linker,et al.  Acetylcholinesterase Accelerates Assembly of Amyloid-β-Peptides into Alzheimer's Fibrils: Possible Role of the Peripheral Site of the Enzyme , 1996, Neuron.

[34]  C. Geula,et al.  Neurobiology of butyrylcholinesterase , 2003, Nature Reviews Neuroscience.

[35]  W. Koppenol,et al.  Nitration and hydroxylation of phenolic compounds by peroxynitrite. , 1996, Methods in enzymology.

[36]  Maria Laura Bolognesi,et al.  Multitargeted drugs discovery: balancing anti-amyloid and anticholinesterase capacity in a single chemical entity. , 2011, Bioorganic & medicinal chemistry letters.

[37]  B. Platt,et al.  Acetylcholine: Future research and perspectives , 2011, Behavioural Brain Research.

[38]  N. Inestrosa,et al.  Acetylcholinesterase promotes the aggregation of amyloid-beta-peptide fragments by forming a complex with the growing fibrils. , 1997, Journal of molecular biology.

[39]  M. Rayman,et al.  The importance of selenium to human health , 2000, The Lancet.

[40]  C. Wagner,et al.  Reduction of diphenyl diselenide and analogs by mammalian thioredoxin reductase is independent of their gluthathione peroxidase-like activity: a possible novel pathway for their antioxidant activity. , 2010, Molecules.

[41]  W. Cheng,et al.  Selenoproteins and the aging brain , 2010, Mechanisms of Ageing and Development.

[42]  S. Pinton,et al.  Therapeutic effect of organoselenium dietary supplementation in a sporadic dementia of Alzheimer's type model in rats. , 2013, The Journal of nutritional biochemistry.

[43]  J. Buccafusco,et al.  Multiple central nervous system targets for eliciting beneficial effects on memory and cognition. , 2000, The Journal of pharmacology and experimental therapeutics.

[44]  H. Sies,et al.  Chemistry of biologically important synthetic organoselenium compounds. , 2001, Chemical reviews.

[45]  Li Di,et al.  High throughput artificial membrane permeability assay for blood-brain barrier. , 2003, European journal of medicinal chemistry.

[46]  José Marco-Contelles,et al.  Recent advances in the multitarget‐directed ligands approach for the treatment of Alzheimer's disease , 2013, Medicinal research reviews.

[47]  V. Andrisano,et al.  Chemical and Pharmacological Studies on Enantiomerically Pure p‐Methoxytacripyrines, Promising Multi‐Target‐Directed Ligands for the Treatment of Alzheimer’s Disease , 2011, ChemMedChem.

[48]  J. Rocha,et al.  Toxicology and pharmacology of selenium: emphasis on synthetic organoselenium compounds , 2011, Archives of Toxicology.

[49]  N. Kooy,et al.  Agonist-induced peroxynitrite production from endothelial cells. , 1994, Archives of biochemistry and biophysics.

[50]  R. Radi,et al.  Pathways of peroxynitrite oxidation of thiol groups. , 1997, The Biochemical journal.

[51]  R. Guigó,et al.  Characterization of Mammalian Selenoproteomes , 2003, Science.

[52]  C. Pérez,et al.  Novel tacrine-8-hydroxyquinoline hybrids as multifunctional agents for the treatment of Alzheimer's disease, with neuroprotective, cholinergic, antioxidant, and copper-complexing properties. , 2010, Journal of medicinal chemistry.

[53]  B. Freeman,et al.  Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. , 1991, Archives of biochemistry and biophysics.

[54]  C. Luchese,et al.  Diphenyl diselenide in its selenol form has dehydroascorbate reductase and glutathione S‐transferase‐like activity dependent on the glutathione content , 2010, The Journal of pharmacy and pharmacology.

[55]  V. Andrisano,et al.  beta-Amyloid aggregation induced by human acetylcholinesterase: inhibition studies. , 2003, Biochemical pharmacology.

[56]  G. Ciapetti,et al.  Serum concentrations of zinc and selenium in elderly people: results in healthy nonagenarians/centenarians , 2001, Experimental Gerontology.